850140-72-6 Afatinib 98%

Our product segment encompasses a diverse range of pharmaceutical offerings, catering to various therapeutic areas and market needs. We prioritize the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, ensuring the highest standards of quality and efficacy. In the API segment, we specialize in the production of a wide array of APIs, including oncology APIs and the latest developments in the field. These APIs undergo stringent quality control processes and adhere to international pharmacopoeia standards. Additionally, our intermediate segment plays a crucial role in the synthesis and production of APIs. We offer a comprehensive range of high-quality intermediates that serve as building blocks for pharmaceutical manufacturing processes.